Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival

Abstract Introduction Concurrent chemoradiation is the standard of care in inoperable locally advanced squamous cell head and neck cancers. The most widely accepted schedule of concomitant cisplatin is 100mg/m2 given on a 3 weekly basis but the optimal regime is unknown. Ob...

Full description

Bibliographic Details
Main Authors: Muhammad Shahid Iqbal, Cheng Chaw, Josef Kovarik, Shahzeena Aslam, Aaron Jackson, John Kelly, Werner Dobrowsky, Charles Kelly
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2017-04-01
Series:International Archives of Otorhinolaryngology
Subjects:
head and neck neoplasms
chemoradiotherapy
cisplatin
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1594020

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1594020

Similar Items